The Pharmacy Times® Allergy Resource Center is a comprehensive resource for clinical news and expert insights on issues related to conditions that cause the immune system to react abnormally to a foreign substance, including seasonal allergies, food allergies, drug allergies, and contact dermatitis.
April 25th 2025
NS-229 is a Janus kinase 1 (JAK1) inhibitor being investigated in eosinophilic granulomatosis with polyangiitis, a rare autoimmune condition that can cause severe allergic and asthmatic symptoms through inflammation of nerve cells.
Study: Asthma, Hay Fever, Other Allergies Not Linked to Mental Health Traits
October 29th 2021Evidence of a causal relationship between the onset of allergic disease and mental health was limited, suggesting that the observational associations found were due to confounding or other forms of bias.
Read More
According to Ocular Therapeutix, Dextenza is now the first FDA-approved, physician-administered intracanalicular insert capable of delivering a preservative-free drug for the treatment of ocular itching associated with allergic conjunctivitis with a single administration for up to 30 days.
Read More